MakingPharmaIndustryLuogo di incontro per approfondire e discutere le più importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business
With its oncology drugs in decline and a string of recent failures on Alzheimer's, the Swiss giant veers into Inflammatory Bowel Diseases (IBD) by securing for more than 7 billion the U.S. rights to an investigational new drug.
The 62° AFI National Symposium opens with an initial session devoted to the evolution of advanced therapies for safer, more effective and accessible drugs for patients.
DARWIN EU, acronym for Data Analysis and Real World Interrogation Network, is the new long-term project of EMA, the European Medicines Agency. The objective...